Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R7HA
|
||||
Former ID |
DIB007176
|
||||
Drug Name |
DPP-IV inhibitors
|
||||
Synonyms |
DPP-IV inhibitors (type 2 diabetes); DPP-IV inhibitors (type 2 diabetes), Biovitrum; DPP-IV inhibitors (type 2 diabetes), Santhera; Dipeptidyl-peptidase IV inhibitors (type 2 diabetes), Santhera
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [552161] | ||
Company |
Graffinity Pharmaceuticals AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1CC[C@H](N1C(=O)C[C@@H](Cc1cccc(c1)Cl)N)CNC(=O)c1cc(cc<br />c1)S(=O)(=O)C
|
||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [543447] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.